Data sharing ambitions set out in newly published sustainability and transformation plans (STPs) have been given a boost by a new strategic partnership between data management specialist Stalis and Italy's largest health IT company, Dedalus. The new partnership looks to make vital patient information, currently stored on dozens or even hundreds of legacy IT systems, accessible for care professionals working in different NHS and public sector organisations.
Munich Leukemia Laboratory (MLL), a state-of-the-art leukemia and lymphoma diagnostic and research laboratory based in Munich, has teamed up with IBM (NYSE: IBM) and Illumina, Inc. (NASDAQ: ILMN) to help build a new cognitive technology prototype that aims to help researchers improve leukemia treatment.
Royal Philips (NYSE: PHG, AEX: PHIA) and LabPON, the first clinical laboratory to transition to 100% histopathology digital diagnosis, have announced its plans to create a digital database of massive aggregated sets of annotated pathology images and big data utilizing Philips IntelliSite Pathology Solution (1).
Allscripts (NASDAQ:MDRX) announced it was accepted onto the NHS London Procurement Partnership (LPP) Clinical and Digital Information Systems (CDIS) Framework in both the acute care and innovation categories. CDIS, which went live in December 2016, was created to enable health and social care organisations to comply with the National Information Board's Personalised Health and Care 2020 framework.
25 - 27 April 2017, Berlin, Germany.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has unveiled new advanced radiology solutions at the 2017 European Congress of Radiology (ECR). In response to today's increasingly value-based focus in healthcare, Philips' newest integrated innovations are centered on empowering radiologists to deliver more value across the healthcare continuum.